RAPID MICRO BIOSYSTEMS, INC. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rapid Micro Biosystems, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
  • Rapid Micro Biosystems, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$13.4M, a 11.1% increase year-over-year.
  • Rapid Micro Biosystems, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$54.3M, a 15.3% increase year-over-year.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2023 was -$56.6M, a 10.5% increase from 2022.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2022 was -$63.2M, a 33.8% decline from 2021.
  • Rapid Micro Biosystems, Inc. annual Operating Income (Loss) for 2021 was -$47.2M, a 54.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$54.3M -$13.4M +$1.68M +11.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$56M -$14.3M +$599K +4.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$56.6M -$12.2M +$5.07M +29.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$61.6M -$14.4M +$2.44M +14.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$64.1M -$15.1M -$980K -6.96% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$63.1M -$14.9M +$127K +0.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$63.2M -$17.3M -$2.7M -18.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$60.5M -$16.9M -$4.76M -39.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$55.8M -$14.1M -$3.21M -29.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$52.5M -$15M -$5.31M -54.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$47.2M -$14.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$12.1M -$4.55M -60% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$10.9M -$4.85M -80.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$9.69M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$7.58M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$6.01M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.